Status:
ACTIVE_NOT_RECRUITING
Diagnostic Values of Urothelial Carcinomas: Single-bolus Versus Split-bolus Computed Tomography Urography
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Urothelial Carcinoma
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Single-bolus computed tomography urography (CTU)is a recently developed one-stop imaging examination for diagnosis of urinary tract diseases, including urinary malignancies. However, single-bolus CTU ...
Detailed Description
This study will enroll 352 patients. The calculation of sample size is according to the following equation: n2=〖(Z∝+Zβ/2)〗\^2/〖(δ-\|ε\|)〗\^2 \[p1(1-p1)/k+p1(1-p2)\] ∝=0.05, β=0.2, δ=0.05, p1=0.96, p...
Eligibility Criteria
Inclusion
- Fitting all of the followings
- age ≥ 40 years old
- presenting with gross hematuria or having a history of urothelial carcinomas
- normal renal function (i.e.: estimated glomerular filtration rate ≧ 60 mL/min/1.73 m2)
- no allergy history of iodinated contrast medium
Exclusion
- Fitting any of the followings
- pregnant or lactating woman
- withdrawal of informed consent
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT04113603
Start Date
June 1 2019
End Date
December 30 2025
Last Update
February 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Li-Jen Wang
Taoyuan District, Ta, Taiwan, 333